Li Geng, Wang Hua, Dong Zheng-Qi, Wang Ying-Ping, Wang Tao, Yao Xia, Chen Ying, Jia Hai-Bin, Sun Xiao-Bo
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100193, China Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
School of Pharmacy, Jiangxi University of Chinese Medicine Nanchang 330004, China.
Zhongguo Zhong Yao Za Zhi. 2024 Sep;49(17):4818-4828. doi: 10.19540/j.cnki.cjcmm.20240615.102.
Ginseng Radix et Rhizoma is a unique traditional Chinese herbal medicine in China, with a long medicinal history, unique healthcare effects, and a profound cultural value. The development of the Ginseng Radix et Rhizoma industry has practical and symbolic significance for the traditional Chinese medicine(TCM) industry. Under the new situation, China's Ginseng Radix et Rhizoma industry has faced new development opportunities and also internal and external challenges. It is urgent to deeply analyze the practical problems and explore the solutions. This article systematically reviews the current situation of China's Ginseng Radix et Rhizoma industry from the industrial chain and analyzes the current problems and development trends of this industry, aiming to provide reference and a decision-making basis for the high-quality development of this industry.
人参是我国特有的传统中药材，药用历史悠久，保健作用独特，文化价值深厚。人参产业的发展对中医药产业具有现实和象征意义。在新形势下，我国人参产业既面临新的发展机遇，也面临内外部挑战。深入分析实际问题并探索解决方案迫在眉睫。本文从产业链角度系统回顾了我国人参产业的现状，分析了该产业当前存在的问题及发展趋势，旨在为该产业的高质量发展提供参考和决策依据。
